Literature DB >> 1445692

Oncogene activation in rheumatoid synovium.

A Trabandt1, R E Gay, S Gay.   

Abstract

Rheumatoid arthritis (RA) is a chronic systemic disorder that is dominated by the debilitating sequelae associated with the progressive destruction of articular joints. The molecular and cellular basis of rheumatoid joint destruction is characterized by an abnormal expression of oncogenes modulating cellular proliferation and the induction of lysosomal and metalloproteinases. Based on the observation that the synovial hyperplasia in RA is associated with the proliferation of transformed-appearing synovial lining cells and an overexpression of such oncogenes, the possibility that a hitherto unknown HTLV related retrovirus is involved in the etiopathogenesis of RA is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445692     DOI: 10.1111/j.1699-0463.1992.tb04012.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

Review 1.  Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule.

Authors:  Karl M Stuhlmeier
Journal:  Wien Med Wochenschr       Date:  2006-11

Review 2.  [Pathogenesis of RA: more than just immune cells].

Authors:  U Müller-Ladner; T Pap
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

3.  Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue.

Authors:  T Rème; A Travaglio; E Gueydon; L Adla; C Jorgensen; J Sany
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.

Authors:  Xinwen Yang; Jianhua Wang; Cunren Liu; William E Grizzle; Shaohua Yu; Shuangqin Zhang; Stephen Barnes; William J Koopman; John D Mountz; Robert P Kimberly; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

5.  [Analysis of gene expression patterns in rheumatoid synovial fibroblasts using RAP-PCR for differential display].

Authors:  U Müller-Ladner; M Judex; H P Jüsten; D Wessinghage; J Welsh; M McClelland; S Gay; J Schölmerich; F Kullmann
Journal:  Med Klin (Munich)       Date:  1999-04-15

6.  Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis.

Authors:  J Kriegsmann; A Berndt; T Hansen; L Borsi; L Zardi; R Bräuer; P K Petrow; M Otto; C J Kirkpatrick; S Gay; H Kosmehl
Journal:  Rheumatol Int       Date:  2003-04-24       Impact factor: 2.631

Review 7.  [Pathogenesis of rheumatoid arthritis].

Authors:  T Geiler; H M Lorenz; J R Kalden; B Manger
Journal:  Med Klin (Munich)       Date:  1997-06-15

Review 8.  [Rheumatoid arthritis: new molecular and cellular aspects].

Authors:  O Distler; U Müller-Ladner; J Schölmerich; R E Gay; S Gay
Journal:  Med Klin (Munich)       Date:  1999-12-15

9.  The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Sho Mokuda; Tatsuhiko Miyazaki; Yuki Ito; Satoshi Yamasaki; Hiroko Inoue; Yun Guo; Weng-Sheng Kong; Masamoto Kanno; Kiyoshi Takasugi; Eiji Sugiyama; Junya Masumoto
Journal:  Sci Rep       Date:  2015-05-22       Impact factor: 4.379

10.  The pro-apoptotic effects of TIPE2 on AA rat fibroblast-like synoviocytes via regulation of the DR5-caspase-NF-κB pathway in vitro.

Authors:  Chunyan Shi; Shifeng Zhang; Shifu Hong; Jinglong Pang; Yeletai Yesibulati; Ping Yin; Guohong Zhuang
Journal:  Onco Targets Ther       Date:  2016-02-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.